According to Bloomberg.com, Mexico’s Genomma Lab Internacional SAB rose the most in July as Chief Executive Officer Rodrigo Herrera said the company was on pace to meet its sales growth projections this year.
The drug company is “comfortable” with the forecast of net sales growth of 5.2 percent in 2015, Herrera said in a phone interview with Bloomberg.com on Friday July 17th.
Its fourth-quarter results shocked shareholder Westwood International Advisors Inc., according to Richard Dolhun, an analyst at the firm. Genomma is due to publish its second-quarter earnings and hold a conference call with investors this week.
“We’re going to hold their feet to the fire,” Dolhun, whose firm oversees $5 billion in equities including Genomma, said by phone. “They have to have a tight message. They have to hit on what they’ve promised.”
Shares of Genomma increased 3.1 percent to 16.29 pesos at 12:35 p.m. in Mexico City. The benchmark IPC equity index rose 0.6 percent on Monday July 20th.
more recommended stories
K’u’uk: contemporary cuisine or pure alchemy?
Acknowledged at the Food and Travel.
Mérida, one of the best cities to live in Mexico (and the world)
Dan Prescher wrote an article for.
Hacienda Kancabchén: a call from a distant era just 15 miles away from Mérida
Hacienda Kancabchén maintains great part of.
Amazon launches new debit card in México
MEXICO CITY.- Banorte and Mastercard, together.
Over two thousand dogs and cats have been vaccinated in Valladolid
With the installation of seven locations.
Yucatecan pelicans and flamingos on the brink of becoming endangered species
“Pelicans and flamingos are some of.
Teacher Leaders Present an Innovative Blueprint for Relevant Learning in the Age of AI
What does the fourth industrial revolution.
New technology used in Yucatán to find people lost at sea
As part of a third aspect.
“Pet uh” Civil Association aims to promote Peto, Yucatán
PETO.- In the coming weeks the.
Mexico overtakes Brazil as the largest automobile producer in Latin America
Mexico registered a new record in.